Top Latin America PoC Diagnostic Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Latin America PoC Diagnostic Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Latin America PoC Diagnostic industry players.

Latin America PoC Diagnostic Market Competitive Landscape

The majority of these businesses have offices in major economies like Brazil, Mexico, and Chile, but they sell and supply products through distributors and subsidiaries in Latin American nations.

In addition, there is a lot of competition in the market and distribution network because other medical equipment distributors offer their products in different nations. More effective POC diagnostic testing devices are being developed and manufactured by rival companies with a focus on clinics, hospitals, assisted living facilities, and home healthcare. This is expected to increase demand for POC devices and propel the market's expansion.

Latin America PoC Diagnostic Market Top Players Company Profile

  • Abbott Laboratories

  • Roche Diagnostics

     

  • Siemens Healthineers

     

  • BD (Becton, Dickinson and Company)

     

  • bioMérieux SA

     

  • QIAGEN N.V.

     

  • Hologic Inc.

     

  • Danaher Corporation

     

  • Alere Inc.

  • bioLytical Laboratories

    Chembio Diagnostic Systems, Inc.

    CTK Biotech, Inc.

    Meridian Bioscience, Inc.

    Trinity Biotech

    Sysmex Corporation

    Sekisui Diagnostics LLC

    Nova Biomedical

    EKF Diagnostics Holdings plc

    Abacus Diagnostica Oy

    Fio Corporation

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Latin America PoC Diagnostic Market size was valued at USD 3.69 Billion in 2024 and is poised to grow from USD 4 Billion in 2025 to USD 7.63 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026–2033). 

The majority of these businesses have offices in major economies like Brazil, Mexico, and Chile, but they sell and supply products through distributors and subsidiaries in Latin American nations. 'Abbott Laboratories (US) ', 'Roche Diagnostics (Switzerland) ', 'Siemens Healthineers (Germany) ', 'Danaher Corporation (US) ', 'bioMérieux (France) ', 'BD (Becton, Dickinson and Company) (US) ', 'QuidelOrtho Corporation (US) ', 'EKF Diagnostics Holdings plc (UK) ', 'OraSure Technologies, Inc. (US) ', 'ACON Laboratories, Inc. (US) ', 'Abaxis, Inc. (US) ', 'Arkray, Inc. (Japan) ', 'Biomerica Inc. (US) ', 'Labtest Diagnóstica (Brazil) ', 'Wiener Laboratorios (Argentina) ', 'Diagnostic Grifols (Spain) ', 'Diasorin S.p.A. (Italy) '

Around the world, a significant rise in the prevalence of chronic diseases like diabetes, cardiovascular problems, and infectious diseases has been observed. One of the primary drivers of the anticipated rise in demand for point-of-care diagnostics is the high prevalence rate of such conditions. Due to the need for accurate and speedy treatment decisions, point-of-care testing has become essential for patient-centered healthcare. Patients now have easy access to these diagnostics thanks to the transition from centralized point-of-care testing to decentralized testing for chronic, infectious, and chronic conditions.

The prevalence of chronic and endemic diseases like Chagas in less developed regions is expected to increase market potential, and the adoption of a sedentary lifestyle by the young and middle-aged population is estimated to contribute to the prevalence of diabetes, cardiac disease, drug abuse, and STDs in developing nations.

Brazil was the largest point of care diagnostics market in Latin America. This was due to the growing economy's increased spending power and government efforts to control and prevent the prevalence of chronic and endemic diseases. In addition, healthcare organizations like WHO and PAHO's early disease diagnosis initiatives and awareness programs account for the majority of the region's market revenue. Due to the rapid increase in the aging population and high prevalence of chronic, endemic, and infectious diseases like Chagas, as well as infectious diseases like HIC, syphilis, and RSV, Chile is expected to be the Latin American market for POC diagnostics with the fastest growth. The Latin American point of care diagnostics market is anticipated to be driven by high unmet diagnostic needs, rising per capita income, rising medical awareness, and efforts to improve healthcare infrastructure.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Veterinary POC Diagnostics Market
Buy Now GET FREE SAMPLE
Latin America In Vitro Diagnostics Market
Buy Now GET FREE SAMPLE
Latin America Medical Imaging Market
Buy Now GET FREE SAMPLE
Rapid Diagnostics Market
Buy Now GET FREE SAMPLE
Infectious Disease Diagnostics Market
Buy Now GET FREE SAMPLE
Point Of Care Diagnostics Market
Buy Now GET FREE SAMPLE
Companion Diagnostics Market
Buy Now GET FREE SAMPLE
Rapid Medical Diagnostic Kits Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Latin America PoC Diagnostic Market market
Latin America PoC Diagnostic Market

Report ID: SQMIR35H2247

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE